10-Q 1 form10-q.htm
false Q3 --12-30 0000771266 false false false false 0000771266 2023-01-01 2023-09-30 0000771266 2023-11-03 0000771266 2023-09-30 0000771266 2022-12-31 0000771266 2023-07-02 2023-09-30 0000771266 2022-06-26 2022-09-24 0000771266 2021-12-26 2022-09-24 0000771266 KOPN:NetProductRevenuesMember 2023-07-02 2023-09-30 0000771266 KOPN:NetProductRevenuesMember 2022-06-26 2022-09-24 0000771266 KOPN:NetProductRevenuesMember 2023-01-01 2023-09-30 0000771266 KOPN:NetProductRevenuesMember 2021-12-26 2022-09-24 0000771266 KOPN:ResearchAndDevelopmentRevenuesMember 2023-07-02 2023-09-30 0000771266 KOPN:ResearchAndDevelopmentRevenuesMember 2022-06-26 2022-09-24 0000771266 KOPN:ResearchAndDevelopmentRevenuesMember 2023-01-01 2023-09-30 0000771266 KOPN:ResearchAndDevelopmentRevenuesMember 2021-12-26 2022-09-24 0000771266 KOPN:OtherRevenuesMember 2023-07-02 2023-09-30 0000771266 KOPN:OtherRevenuesMember 2022-06-26 2022-09-24 0000771266 KOPN:OtherRevenuesMember 2023-01-01 2023-09-30 0000771266 KOPN:OtherRevenuesMember 2021-12-26 2022-09-24 0000771266 us-gaap:CommonStockMember 2022-12-31 0000771266 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000771266 us-gaap:TreasuryStockCommonMember 2022-12-31 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000771266 us-gaap:RetainedEarningsMember 2022-12-31 0000771266 us-gaap:ParentMember 2022-12-31 0000771266 us-gaap:NoncontrollingInterestMember 2022-12-31 0000771266 us-gaap:CommonStockMember 2023-04-01 0000771266 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 0000771266 us-gaap:TreasuryStockCommonMember 2023-04-01 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 0000771266 us-gaap:RetainedEarningsMember 2023-04-01 0000771266 us-gaap:ParentMember 2023-04-01 0000771266 us-gaap:NoncontrollingInterestMember 2023-04-01 0000771266 2023-04-01 0000771266 us-gaap:CommonStockMember 2023-07-01 0000771266 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 0000771266 us-gaap:TreasuryStockCommonMember 2023-07-01 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 0000771266 us-gaap:RetainedEarningsMember 2023-07-01 0000771266 us-gaap:ParentMember 2023-07-01 0000771266 us-gaap:NoncontrollingInterestMember 2023-07-01 0000771266 2023-07-01 0000771266 us-gaap:CommonStockMember 2021-12-25 0000771266 us-gaap:AdditionalPaidInCapitalMember 2021-12-25 0000771266 us-gaap:TreasuryStockCommonMember 2021-12-25 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-25 0000771266 us-gaap:RetainedEarningsMember 2021-12-25 0000771266 us-gaap:ParentMember 2021-12-25 0000771266 us-gaap:NoncontrollingInterestMember 2021-12-25 0000771266 2021-12-25 0000771266 us-gaap:CommonStockMember 2022-03-26 0000771266 us-gaap:AdditionalPaidInCapitalMember 2022-03-26 0000771266 us-gaap:TreasuryStockCommonMember 2022-03-26 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-26 0000771266 us-gaap:RetainedEarningsMember 2022-03-26 0000771266 us-gaap:ParentMember 2022-03-26 0000771266 us-gaap:NoncontrollingInterestMember 2022-03-26 0000771266 2022-03-26 0000771266 us-gaap:CommonStockMember 2022-06-25 0000771266 us-gaap:AdditionalPaidInCapitalMember 2022-06-25 0000771266 us-gaap:TreasuryStockCommonMember 2022-06-25 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-25 0000771266 us-gaap:RetainedEarningsMember 2022-06-25 0000771266 us-gaap:ParentMember 2022-06-25 0000771266 us-gaap:NoncontrollingInterestMember 2022-06-25 0000771266 2022-06-25 0000771266 us-gaap:CommonStockMember 2023-01-01 2023-04-01 0000771266 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-04-01 0000771266 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-04-01 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-04-01 0000771266 us-gaap:RetainedEarningsMember 2023-01-01 2023-04-01 0000771266 us-gaap:ParentMember 2023-01-01 2023-04-01 0000771266 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-04-01 0000771266 2023-01-01 2023-04-01 0000771266 us-gaap:CommonStockMember 2023-04-02 2023-07-01 0000771266 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 2023-07-01 0000771266 us-gaap:TreasuryStockCommonMember 2023-04-02 2023-07-01 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 2023-07-01 0000771266 us-gaap:RetainedEarningsMember 2023-04-02 2023-07-01 0000771266 us-gaap:ParentMember 2023-04-02 2023-07-01 0000771266 us-gaap:NoncontrollingInterestMember 2023-04-02 2023-07-01 0000771266 2023-04-02 2023-07-01 0000771266 us-gaap:CommonStockMember 2023-07-02 2023-09-30 0000771266 us-gaap:CommonStockMember 2021-12-26 2022-03-26 0000771266 us-gaap:AdditionalPaidInCapitalMember 2021-12-26 2022-03-26 0000771266 us-gaap:TreasuryStockCommonMember 2021-12-26 2022-03-26 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-26 2022-03-26 0000771266 us-gaap:RetainedEarningsMember 2021-12-26 2022-03-26 0000771266 us-gaap:ParentMember 2021-12-26 2022-03-26 0000771266 us-gaap:NoncontrollingInterestMember 2021-12-26 2022-03-26 0000771266 2021-12-26 2022-03-26 0000771266 us-gaap:CommonStockMember 2022-03-27 2022-06-25 0000771266 us-gaap:AdditionalPaidInCapitalMember 2022-03-27 2022-06-25 0000771266 us-gaap:TreasuryStockCommonMember 2022-03-27 2022-06-25 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-27 2022-06-25 0000771266 us-gaap:RetainedEarningsMember 2022-03-27 2022-06-25 0000771266 us-gaap:ParentMember 2022-03-27 2022-06-25 0000771266 us-gaap:NoncontrollingInterestMember 2022-03-27 2022-06-25 0000771266 2022-03-27 2022-06-25 0000771266 us-gaap:CommonStockMember 2022-06-26 2022-09-24 0000771266 us-gaap:AdditionalPaidInCapitalMember 2022-06-26 2022-09-24 0000771266 us-gaap:TreasuryStockCommonMember 2022-06-26 2022-09-24 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-26 2022-09-24 0000771266 us-gaap:RetainedEarningsMember 2022-06-26 2022-09-24 0000771266 us-gaap:ParentMember 2022-06-26 2022-09-24 0000771266 us-gaap:NoncontrollingInterestMember 2022-06-26 2022-09-24 0000771266 us-gaap:CommonStockMember 2023-09-30 0000771266 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000771266 us-gaap:TreasuryStockCommonMember 2023-09-30 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000771266 us-gaap:RetainedEarningsMember 2023-09-30 0000771266 us-gaap:ParentMember 2023-09-30 0000771266 us-gaap:NoncontrollingInterestMember 2023-09-30 0000771266 us-gaap:CommonStockMember 2022-09-24 0000771266 us-gaap:AdditionalPaidInCapitalMember 2022-09-24 0000771266 us-gaap:TreasuryStockCommonMember 2022-09-24 0000771266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-24 0000771266 us-gaap:RetainedEarningsMember 2022-09-24 0000771266 us-gaap:ParentMember 2022-09-24 0000771266 us-gaap:NoncontrollingInterestMember 2022-09-24 0000771266 2022-09-24 0000771266 KOPN:EMDTMember 2022-09-24 0000771266 2023-01-26 2023-01-27 0000771266 KOPN:PrefundedWarrantsMember 2023-01-27 0000771266 KOPN:PrefundedWarrantsMember 2023-01-26 2023-01-27 0000771266 KOPN:LSTAgreementMember KOPN:LightningSiliconTechnologyIncMember 2023-01-04 2023-01-05 0000771266 KOPN:LSTAgreementMember KOPN:LightningSiliconTechnologyIncMember 2023-01-05 0000771266 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2023-09-30 0000771266 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0000771266 KOPN:CorporateDebtAndCertificatesOfDepositMember 2023-09-30 0000771266 KOPN:CorporateDebtAndCertificatesOfDepositMember 2022-12-31 0000771266 KOPN:CorporateDebtAndCertificateOfDepositMember 2023-09-30 0000771266 us-gaap:CashAndCashEquivalentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2023-09-30 0000771266 KOPN:USGovernmentAndAgencyBackedSecuritiesMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel1Member KOPN:USGovernmentAndAgencyBackedSecuritiesMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel2Member KOPN:USGovernmentAndAgencyBackedSecuritiesMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel3Member KOPN:USGovernmentAndAgencyBackedSecuritiesMember 2023-09-30 0000771266 us-gaap:CertificatesOfDepositMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2023-09-30 0000771266 KOPN:EquityInvestmentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel1Member KOPN:EquityInvestmentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel2Member KOPN:EquityInvestmentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel3Member KOPN:EquityInvestmentsMember 2023-09-30 0000771266 us-gaap:FairValueInputsLevel1Member 2023-09-30 0000771266 us-gaap:FairValueInputsLevel2Member 2023-09-30 0000771266 us-gaap:FairValueInputsLevel3Member 2023-09-30 0000771266 us-gaap:CashAndCashEquivalentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0000771266 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000771266 us-gaap:CertificatesOfDepositMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2022-12-31 0000771266 us-gaap:EquityMethodInvestmentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel1Member us-gaap:EquityMethodInvestmentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel2Member us-gaap:EquityMethodInvestmentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel3Member us-gaap:EquityMethodInvestmentsMember 2022-12-31 0000771266 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000771266 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000771266 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000771266 us-gaap:EquityMethodInvestmentsMember 2023-01-01 2023-09-30 0000771266 2019-09-29 2019-12-28 0000771266 2019-12-28 0000771266 2022-04-26 2022-06-25 0000771266 2023-04-02 2023-07-03 0000771266 2023-06-30 2023-09-30 0000771266 KOPN:EquityInvestmentMember 2023-09-30 0000771266 KOPN:AssetPurchaseAgreementMember 2019-09-30 2019-09-30 0000771266 KOPN:AssetPurchaseAgreementMember 2019-09-30 0000771266 KOPN:AssetPurchaseAgreementMember 2023-06-30 2023-09-30 0000771266 KOPN:AssetPurchaseAgreementMember 2023-01-01 2023-09-30 0000771266 KOPN:PrefundedWarrantsMember us-gaap:OverAllotmentOptionMember 2023-01-26 2023-01-27 0000771266 us-gaap:CommonStockMember 2022-03-27 2022-06-25 0000771266 KOPN:PrefundedWarrantsMember us-gaap:TreasuryStockCommonMember 2022-03-27 2022-06-25 0000771266 KOPN:PrefundedWarrantsMember 2022-03-27 2022-06-25 0000771266 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0000771266 us-gaap:RestrictedStockUnitsRSUMember 2021-12-26 2022-09-24 0000771266 KOPN:TimeBasedMember 2023-01-01 2023-09-30 0000771266 KOPN:TimeBasedMember 2021-12-26 2022-09-24 0000771266 KOPN:SuccessfulAchievementOfMilestonesMember 2023-01-01 2023-09-30 0000771266 KOPN:SuccessfulAchievementOfMilestonesMember 2021-12-26 2022-09-24 0000771266 us-gaap:WarrantMember 2023-01-01 2023-09-30 0000771266 us-gaap:SalesRevenueNetMember 2023-01-01 2023-09-30 0000771266 us-gaap:WarrantMember 2023-09-30 0000771266 srt:MaximumMember 2023-07-02 2023-09-30 0000771266 srt:MaximumMember 2022-06-26 2022-09-24 0000771266 us-gaap:TransferredAtPointInTimeMember 2023-07-02 2023-09-30 0000771266 us-gaap:TransferredAtPointInTimeMember 2022-06-26 2022-09-24 0000771266 us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0000771266 us-gaap:TransferredAtPointInTimeMember 2021-12-26 2022-09-24 0000771266 us-gaap:TransferredOverTimeMember 2023-07-02 2023-09-30 0000771266 us-gaap:TransferredOverTimeMember 2022-06-26 2022-09-24 0000771266 us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0000771266 us-gaap:TransferredOverTimeMember 2021-12-26 2022-09-24 0000771266 country:US 2023-09-30 0000771266 country:US 2022-12-31 0000771266 country:GB 2023-09-30 0000771266 country:GB 2022-12-31 0000771266 country:US 2023-07-02 2023-09-30 0000771266 country:US 2022-06-26 2022-09-24 0000771266 country:US 2023-01-01 2023-09-30 0000771266 country:US 2021-12-26 2022-09-24 0000771266 KOPN:OtherAmericasMember 2023-07-02 2023-09-30 0000771266 KOPN:OtherAmericasMember 2022-06-26 2022-09-24 0000771266 KOPN:OtherAmericasMember 2023-01-01 2023-09-30 0000771266 KOPN:OtherAmericasMember 2021-12-26 2022-09-24 0000771266 KOPN:TotalAmericasMember 2023-07-02 2023-09-30 0000771266 KOPN:TotalAmericasMember 2022-06-26 2022-09-24 0000771266 KOPN:TotalAmericasMember 2023-01-01 2023-09-30 0000771266 KOPN:TotalAmericasMember 2021-12-26 2022-09-24 0000771266 srt:AsiaPacificMember 2023-07-02 2023-09-30 0000771266 srt:AsiaPacificMember 2022-06-26 2022-09-24 0000771266 srt:AsiaPacificMember 2023-01-01 2023-09-30 0000771266 srt:AsiaPacificMember 2021-12-26 2022-09-24 0000771266 srt:EuropeMember 2023-07-02 2023-09-30 0000771266 srt:EuropeMember 2022-06-26 2022-09-24 0000771266 srt:EuropeMember 2023-01-01 2023-09-30 0000771266 srt:EuropeMember 2021-12-26 2022-09-24 0000771266 KOPN:DefenseMember 2023-07-02 2023-09-30 0000771266 KOPN:DefenseMember 2022-06-26 2022-09-24 0000771266 KOPN:DefenseMember 2023-01-01 2023-09-30 0000771266 KOPN:DefenseMember 2021-12-26 2022-09-24 0000771266 KOPN:IndustrialMember 2023-07-02 2023-09-30 0000771266 KOPN:IndustrialMember 2022-06-26 2022-09-24 0000771266 KOPN:IndustrialMember 2023-01-01 2023-09-30 0000771266 KOPN:IndustrialMember 2021-12-26 2022-09-24 0000771266 KOPN:ConsumerMember 2023-07-02 2023-09-30 0000771266 KOPN:ConsumerMember 2022-06-26 2022-09-24 0000771266 KOPN:ConsumerMember 2023-01-01 2023-09-30 0000771266 KOPN:ConsumerMember 2021-12-26 2022-09-24 0000771266 KOPN:ResearchAndDevelopmentMember 2023-07-02 2023-09-30 0000771266 KOPN:ResearchAndDevelopmentMember 2022-06-26 2022-09-24 0000771266 KOPN:ResearchAndDevelopmentMember 2023-01-01 2023-09-30 0000771266 KOPN:ResearchAndDevelopmentMember 2021-12-26 2022-09-24 0000771266 KOPN:LicenseAndRoyaltiesMember 2023-07-02 2023-09-30 0000771266 KOPN:LicenseAndRoyaltiesMember 2022-06-26 2022-09-24 0000771266 KOPN:LicenseAndRoyaltiesMember 2023-01-01 2023-09-30 0000771266 KOPN:LicenseAndRoyaltiesMember 2021-12-26 2022-09-24 0000771266 KOPN:RealWearIncMember 2023-07-02 2023-09-30 0000771266 KOPN:RealWearIncMember 2022-06-26 2022-09-24 0000771266 KOPN:HMDMdIncMember 2023-07-02 2023-09-30 0000771266 KOPN:HMDMdIncMember 2022-06-26 2022-09-24 0000771266 KOPN:LightningSiliconTechonologyIncMember 2023-07-02 2023-09-30 0000771266 KOPN:LightningSiliconTechonologyIncMember 2022-06-26 2022-09-24 0000771266 KOPN:RealWearIncMember 2023-01-01 2023-09-30 0000771266 KOPN:RealWearIncMember 2021-12-26 2022-09-24 0000771266 KOPN:HMDMdIncMember 2023-01-01 2023-09-30 0000771266 KOPN:HMDMdIncMember 2021-12-26 2022-09-24 0000771266 KOPN:LightningSiliconTechonologyIncMember 2023-01-01 2023-09-30 0000771266 KOPN:LightningSiliconTechonologyIncMember 2021-12-26 2022-09-24 0000771266 KOPN:RealWearIncMember 2023-09-30 0000771266 KOPN:RealWearIncMember 2022-12-31 0000771266 KOPN:HMDMdIncMember 2023-09-30 0000771266 KOPN:HMDMdIncMember 2022-12-31 0000771266 KOPN:SolosTechnologyMember 2023-09-30 0000771266 KOPN:SolosTechnologyMember 2022-12-31 0000771266 KOPN:LightningSiliconTechonologyIncMember 2023-09-30 0000771266 KOPN:LightningSiliconTechonologyIncMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission file number 0-19882

 

KOPIN CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   04-2833935

State or other jurisdiction of

incorporation or organization

 

(I.R.S. Employer

Identification No.)

     
125 North Drive, Westborough, MA   01581-3335
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (508) 870-5959

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01   KOPN   Nasdaq Capital Market

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding as of November 3, 2023
Common Stock, par value $0.01   114,449,134

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer   Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No

 

 

 

 

 

 

Kopin Corporation

 

INDEX

 

    Page No.
Part I – Financial Information  
     
Item 1. Condensed Consolidated Financial Statements (Unaudited) 3
     
  Condensed Consolidated Balance Sheets at September 30, 2023 (Unaudited) and December 31, 2022 3
     
  Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2023 and September 24, 2022 4
     
  Condensed Consolidated Statements of Comprehensive Loss (Unaudited) for the three and nine months ended September 30, 2023 and September 24, 2022 5
     
  Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) for the three and nine months ended September 30, 2023 and September 24, 2022 6
     
  Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2023 and September 24, 2022 7
     
  Notes to Unaudited Condensed Consolidated Financial Statements 8
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 23
     
Item 4. Controls and Procedures 23
     
Part II – Other Information 24
     
Item 1. Legal Proceedings 24
     
Item 1A. Risk Factors 25
     
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities 25
     
Item 6. Exhibits 25
     
Signatures 26

 

2
 

 

Part 1. FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements (Unaudited)

 

KOPIN CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   September 30, 2023   December 31, 2022 
   (unaudited)     
ASSETS          
Current assets:          
Cash and cash equivalents  $9,599,675   $8,258,878 
Restricted cash   500,000     
Marketable debt securities, at fair value   11,610,485    4,388,778 
Accounts receivable, net of allowance of $1,025,000 in 2023 and $303,000 in 2022   7,118,214    6,537,891 
Contract assets and unbilled receivables   5,882,340    4,068,364 
Inventory   9,074,492    6,426,400 
Prepaid taxes   104,671    105,495 
Prepaid expenses and other current assets   1,478,375    1,074,867 
Total current assets   45,368,252    30,860,673 
Property, plant and equipment, net   1,794,832    1,831,641 
Operating lease right-of-use assets   2,670,116    3,168,520 
Other assets   169,132    170,132 
Equity investments   4,603,014    7,721,206 
Total assets  $54,605,346   $43,752,172 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $7,187,025   $5,438,980 
Accrued payroll and expenses   1,717,584    2,879,139 
Accrued warranty   2,161,000    1,966,000 
Contract liabilities and billings in excess of revenues earned   668,046    930,500 
Operating lease liabilities   762,521    786,928 
Accrued post-retirement benefits   790,000    790,000 
Other accrued liabilities   1,765,544    1,182,346 
Customer deposits   559,503     
Deferred tax liabilities   450,480    482,739 
Total current liabilities   16,061,703    14,456,632 
Noncurrent contract liabilities and asset retirement obligations   267,226    248,284 
Operating lease liabilities, net of current portion   2,008,077    2,576,883 
Accrued post-retirement benefits, net of current portion   507,496    1,110,000 
Other long-term obligations, net of current portion   1,391,121    1,369,758 
Total liabilities   20,235,623    19,761,557 
Commitments and contingencies   -     -  
Stockholders’ equity:          
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued        
Common stock, par value $.01 per share: authorized, 150,000,000 shares; issued 114,415,269 shares in 2023 and 94,920,060 shares in 2022; outstanding 110,396,217 in 2023 and 92,883,524 in 2022, respectively   1,104,668    929,540 
Additional paid-in capital   383,898,603    360,567,631 
Treasury stock (70,635 shares in 2023 and 2022, at cost)   (103,127)   (103,127)
Accumulated other comprehensive income   1,135,641    1,176,068 
Accumulated deficit   (351,666,062)   (338,406,815)
Total Kopin Corporation stockholders’ equity   34,369,723    24,163,297 
Noncontrolling interest       (172,682)
Total Kopin Corporation stockholders’ equity   34,369,723    23,990,615 
Total liabilities and stockholders’ equity  $54,605,346   $43,752,172 

 

See notes to unaudited condensed consolidated financial statements

 

3
 

 

KOPIN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three months ended   Three months ended   Nine months ended   Nine months ended 
   September 30, 2023   September 24, 2022   September 30, 2023   September 24, 2022 
Revenues:                    
Net product revenues  $5,506,193   $8,254,686   $19,172,302   $23,765,872 
Research and development revenues   4,956,386    3,374,873    11,737,062    11,089,015 
Other revenues   135,918    99,820    907,180    361,946 
Total revenues   10,598,497    11,729,379    31,816,544    35,216,833 
Expenses:                    
Cost of product revenues   5,437,953    7,987,154    17,759,117    23,676,283 
Research and development   3,089,935    3,441,405    8,534,411    13,995,393 
Selling, general and administration   4,798,598    4,320,117    15,912,848    13,112,133 
Total expenses   13,326,486    15,748,676    42,206,376    50,783,809 
Loss from operations   (2,727,989)   (4,019,297)   (10,389,832)   (15,566,976)
Other income (expense)                    
Interest income   299,506    21,663    623,971    41,195 
Other income (expense), net   31,608    (3,225)   104,403    (7,952)
(Loss) gain on investments       (2,000,000)   (3,327,347)   2,700,000 
Foreign currency transaction losses   (14,438)   (112,315)   (153,442)   (227,294)
Total other income (expense)   316,676    (2,093,877)   (2,752,415)   2,505,949 
Loss before provision for income taxes and net loss attributable to noncontrolling interest   (2,411,313)   (6,113,174)   (13,142,247)   (13,061,027)
Tax provision   (39,000)   (36,000)   (117,000)   (108,000)
Net loss   (2,450,313)   (6,149,174)   (13,259,247)   (13,169,027)
Net loss attributable to the noncontrolling interest               280 
Net loss attributable to Kopin Corporation  $(2,450,313)  $(6,149,174)  $(13,259,247)  $(13,168,747)
Net loss per share                    
Basic and diluted  $(0.02)  $(0.07)  $(0.12)  $(0.14)
Weighted average number of common shares outstanding                    
Basic and diluted   110,360,814    93,516,231    108,436,146    91,317,288 

 

See notes to unaudited condensed consolidated financial statements

 

4
 

 

KOPIN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

 

   Three months ended   Three months ended   Nine months ended   Nine months ended 
   September 30, 2023   September 24, 2022   September 30, 2023   September 24, 2022 
Net loss  $(2,450,313)  $(6,149,174)  $(13,259,247)  $(13,169,027)
Other comprehensive loss, net of tax:                    
Foreign currency translation adjustments   (10,229)   (128,994)   31,955    (170,349)
Unrealized holding loss on marketable securities   (54,175)   (34,110)   (72,382)   (212,889)
Reclassification of holding losses in net loss               (522)
Other comprehensive loss, net of tax   (64,404)   (163,104)   (40,427)   (383,760)
Comprehensive loss   (2,514,717)   (6,312,278)   (13,299,674)   (13,552,787)
Comprehensive loss attributable to the noncontrolling interest               280 
Comprehensive loss attributable to Kopin Corporation  $(2,514,717)  $(6,312,278)  $(13,299,674)  $(13,552,507)

 

See notes to unaudited condensed consolidated financial statements

 

5
 

 

KOPIN CORPORATION

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

   Shares   Amount   Capital   Stock   Income   Deficit   Equity   Interest   Equity 
   Common Stock   Additional Paid-in   Treasury   Accumulated Other Comprehensive   Accumulated   Total Kopin Corporation Stockholders’   Noncontrolling   Total Stockholders’ 
   Shares   Amount   Capital   Stock   Income   Deficit   Equity   Interest   Equity 
Balance, December 31, 2022   92,954,159   $929,540   $360,567,631   $(103,127)  $1,176,068   $(338,406,815)  $24,163,297   $(172,682)  $23,990,615 
Vesting of restricted stock   17,500    175    (175)   -    -    -    -    -    - 
Stock-based compensation expense   -    -    194,190    -    -    -    194,190    -    194,190 
Other comprehensive income   -    -    -    -    6,227    -    6,227    -    6,227 
Issuance of common stock and pre-funded warrants, net of costs   17,000,000    170,000    21,165,000    -    -    -    21,335,000    -    21,335,000 
Acquisition of noncontrolling interest   -    -    (172,682)   -    -    -    (172,682)   172,682    - 
Net loss   -    -    -    -    -    (2,628,555)   (2,628,555)   -    (2,628,555)
Balance, April 1, 2023   109,971,659   $1,099,715   $381,753,964   $(103,127)  $1,182,295   $(341,035,370)  $42,897,477   $-   $42,897,477 
Vesting of restricted stock   404,966    4,050    (4,050)   -    -    -    -    -    - 
Stock-based compensation expense   -    -    1,191,257    -    -    -    1,191,257    -    1,191,257 
Other comprehensive income   -    -    -    -    17,750    -    17,750    -    17,750 
Net loss   -    -    -    -    -    (8,180,379)   (8,180,379)   -    (8,180,379)
Balance, July 1, 2023   110,376,625   $1,103,765   $382,941,171   $(103,127)  $1,200,045   $(349,215,749)  $35,926,105   $-   $35,926,105 
Vesting of restricted stock   90,227    903    (903)   -    -    -    -    -    - 
Stock-based compensation expense   -    -    958,335    -    -    -    958,335    -    958,335 
Other comprehensive loss   -    -    -    -    (64,404)   -    (64,404)   -    (64,404)
Net loss   -    -    -    -    -    (2,450,313)   (2,450,313)   -    (2,450,313)
Balance, September 30, 2023   110,466,852   $1,104,668   $383,898,603   $(103,127)  $1,135,641   $(351,666,062)  $34,369,723   $-   $34,369,723 

 

   Common Stock   Additional Paid-in   Treasury   Accumulated Other Comprehensive   Accumulated   Total Kopin Corporation Stockholders’   Noncontrolling   Total Stockholders’ 
   Shares   Amount   Capital   Stock   Income   Deficit   Equity   Interest   Equity 
Balance, December 25, 2021   90,069,169   $900,691   $356,931,157   $(366,110)  $1,414,351   $(319,080,898)  $39,799,191   $(172,334)  $39,626,857 
Vesting of restricted stock   154,421    1,544    (1,544)   -    -    -    -    -    - 
Stock-based compensation expense   -    -    656,073    -    -    -    656,073    -    656,073 
Other comprehensive loss   -    -    -    -    (113,906)   -    (113,906)   -    (113,906)
Restricted stock for tax withholding obligations   -    -    -    (95,613)   -    -    (95,613)   -    (95,613)
Net loss   -    -    -    -    -    (1,372,641)  $(1,372,641)   (23)   (1,372,664)
Balance, March 26, 2022   90,223,590   $902,235   $357,585,686   $(461,723)  $1,300,445   $(320,453,539)  $38,873,104   $(172,357)  $38,700,747 
Vesting of restricted stock   50,000    500    (500)   -    -    -    -    -    - 
Stock-based compensation expense   -    -    417,033    -    -    -    417,033    -    417,033 
Other comprehensive loss   -    -    -    -    (106,750)   -    (106,750)   -    (106,750)
Sale of registered stock   1,529,047    15,290    1,550,092    461,723    -    -    2,027,105    -    2,027,105 
Net loss   -    -    -    -    -    (5,646,932)   (5,646,932)   (257)   (5,647,189)
Balance, June 25, 2022   91,802,637   $918,025   $359,552,311   $-   $1,193,695   $(326,100,471)  $35,563,560   $(172,614)  $35,390,946 
Vesting of restricted stock   149,422    1,495    (1,495)   -    -    -    -    -    - 
Stock-based compensation expense   -    -    297,549    -    -    -    297,549    -    297,549 
Other comprehensive loss   -    -    -    -    (163,104)   -    (163,104)   -    (163,104)
Sale of registered stock   675,000    6,750    825,486    -    -    -    832,236    -    832,236 
Net loss   -    -    -    -    -    (6,149,174)   (6,149,174)   -    (6,149,174)
Balance, September 24, 2022   92,627,059   $926,270   $360,673,851   $-   $1,030,591   $(332,249,645)  $30,381,067   $(172,614)  $30,208,453 

 

See notes to unaudited condensed consolidated financial statements

 

6
 

 

KOPIN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Nine months ended   Nine months ended 
   September 30, 2023   September 24, 2022 
Cash flows from operating activities:          
Net loss  $(13,259,247)  $(13,169,027)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   498,188    665,217 
Accretion of premium or discount on marketable debt securities       128 
Stock-based compensation   2,343,782    1,370,654 
Foreign currency losses   27,478    339,186 
Change in allowance for credit losses   726,413    4,772 
Write-off of excess inventory   292,405    1,670,993 
Investment impairment (unrealized gains on investments)   2,887,893    (2,700,000)
Loss on sale of property and plant   18,878    202,670 
Income taxes   117,316    107,509 
Changes in other non-cash items   194,890    1,451,478 
Changes in assets and liabilities:          
Accounts receivable   (2,137,460)   3,756,182 
Contract assets and unbilled receivables   

(1,651,437

)   

(2,302,972

)
Inventory   (2,944,672)   (1,944,577)
Prepaid expenses, other current assets and other assets   (461,365)   (272,446)
Accounts payable and accrued expenses   1,799,444    (1,651,538)
Contract liabilities and billings in excess of revenue earned   (244,188)   (3,130,965)
Net cash used in operating activities   (11,791,682)   (15,602,736)
Cash flows from investing activities:          
Other assets   14,656    23,802 
Capital expenditures   

(478,282

)   

(642,146

)
Equity investment purchase       (499,998)
Proceeds from sale of marketable debt securities   10,374,593    1,000,000 
Purchases of marketable debt securities   (17,624,779)   (4,000,042)
Net cash used in investing activities   (7,713,812)   (4,118,384)
Cash flows from financing activities:          
Sale of treasury stock, net of costs       461,723 
Issuance of common stock and pre-funded warrants, net of costs   21,335,000    2,397,618 
Settlements of restricted stock for tax withholding obligations       (95,613)
Net cash provided by financing activities   21,335,000    2,763,728 
Effect of exchange rate changes on cash   11,291    (205,125)
Net increase (decrease) in cash, cash equivalents, and restricted cash   1,840,797    (17,162,517)
Cash, cash equivalents and restricted cash:          
Beginning of period   8,258,878    26,787,931 
End of period  $10,099,675   $9,625,414 

 

See notes to unaudited condensed consolidated financial statements

 

7
 

 

KOPIN CORPORATION

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. BASIS OF PRESENTATION

 

The condensed consolidated financial statements of Kopin Corporation as of September 30, 2023 and for the nine month periods ended September 30, 2023 and September 24, 2022 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.

 

The condensed consolidated financial statements for the nine months ended September 30, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. The condensed consolidated financial statements for the nine months ended September 24, 2022 include the accounts of Kopin Corporation and its wholly owned subsidiaries. Net loss attributable to noncontrolling interest in the Company’s condensed consolidated statements of operations for the nine months ended September 24, 2022 represents the 20% of the results of operations of a former partially owned subsidiary which is allocated to the shareholders of the equity interests not owned by the Company. All intercompany transactions and balances have been eliminated.

 

The Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future.

 

On January 27, 2023, the Company sold 17,000,000 shares of common stock and pre-funded warrants to purchase up to 6,000,000 shares of common stock at a public offering price of $0.99 per share for net proceeds of approximately $21.4 million. The Company believes that its existing cash and cash equivalents will be adequate to satisfy its current operating plans for at least the next twelve months from the issuance of these financial statements. The Company has in the past sold equity securities through at-the-market equity offerings and in the traditional fashion of significant equity offerings. Nonetheless, management monitors the capital markets on an ongoing basis and may consider raising capital if favorable market conditions develop. If the Company’s actual results are less than projected or the Company needs to raise capital for additional liquidity, the Company may be required to do additional equity financings, reduce expenses, or enter into a strategic transaction. However, management can make no assurance that the Company will be able to raise additional capital, reduce expenses sufficiently, or enter into a strategic transaction on terms acceptable to the Company, or at all.

 

On January 5, 2023, the Company entered into a Technology License Agreement and an Asset Purchase Agreement (the “LST Agreements”) with Lightning Silicon Technology, Inc. (“LST”). Pursuant to the LST Agreements, the Company issued a license to LST for certain technology associated with our Organic Light Emitting Technology, transferred in-process development contracts with two customers and accounts receivables that the Company had previously determined were not collectible. The technology license agreement provides for Kopin to transfer certain patents to LST if LST achieves certain milestones; however upon transfer, Kopin will receive a license to the technology. To the extent LST makes improvements to the technology licensed from Kopin, Kopin will receive a license for these improvements for certain markets. Kopin is not obligated to provide any additional funding support to LST. As consideration for the transaction, the Company received 18,000,000 preferred shares in LST, which the Company determined had no fair value as of the transaction date or as of September 30, 2023. While these shares represent a 20.0% equity stake in LST, they do not provide the Company with voting rights to elect LST’s Governance Board. The Company will also receive a royalty based on unit sales of products that utilize the technology licensed. Drs. John Fan, the Company’s former President, CEO and Chairman of the Board, Boryeu Tsaur, a former Executive Vice President of the Company and Hong Choi, the Company’s former Chief Technology Officer terminated their employment with the Company and became investors in and members of the management team of LST. Dr. Fan is the Founder of LST. As a result of this transaction, in 2022 the Company wrote off the two operating lease assets associated with facilities used for the development of our organic light emitting diode (OLED) products.

 

8
 

 

2. ACCOUNTING STANDARDS

 

ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments became effective for smaller reporting companies for fiscal years beginning after December 15, 2022. The amendments in ASU 2016-13 are intended to provide more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. The Company adopted this standard on January 1, 2023 and there was not a material impact.

 

3. CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE DEBT SECURITIES

 

The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents.

 

Restricted cash of approximately $0.5 million is included on the consolidated balance sheet as of September 30, 2023, and represents cash deposited by the Company into a separate account and designated as collateral for a standby letter of credit in the same amount in accordance with contractual agreements.

 

Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value.” The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations.

 

The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three and nine months ended September 30, 2023 and September 24, 2022.

 

Investments in available-for-sale marketable debt securities were as follows at September 30, 2023 and December 31, 2022:

   Amortized Cost   Unrealized
(Losses) Gains
   Fair Value 
   2023   2022   2023   2022   2023   2022 
U.S. government and agency backed securities  $4,500,030   $2,500,006   $(61,715)  $(102,276)  $4,438,315   $2,397,730 
Corporate debt and certificates of deposit   7,250,174    2,000,012    (78,004)   (8,964)   7,172,170    1,991,048 
Total  $11,750,204   $4,500,018   $(139,719)  $(111,240)  $11,610,485   $4,388,778 

 

The contractual maturity of the Company’s marketable debt securities was as follows at September 30, 2023:

   Less than One year   One to Five years   Total 
U.S. government and agency backed securities  $2,468,075   $1,970,240   $4,438,315 
Corporate debt and certificates of deposit   3,724,927    3,447,243    7,172,170 
Total  $6,193,002   $5,417,483   $11,610,485 

 

9
 

 

4. FAIR VALUE MEASUREMENTS

 

Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, based on quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates or yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets.

 

The following table details the fair value measurements of the Company’s financial assets:

   Total   Level 1   Level 2   Level 3 
       Fair Value Measurement at September 30, 2023 Using: 
   Total   Level 1   Level 2   Level 3 
Cash and cash equivalents and restricted cash  $10,099,675   $10,099,675   $   $ 
U.S. government securities   4,438,315        4,438,315     
Certificates of deposit   7,172,170    7,172,170         
Equity investments   4,603,014    169,112        4,433,902 
Financial instruments, owned, at fair value  $26,313,174   $17,440,957   $4,438,315   $4,433,902 

 

   Total   Level 1   Level 2   Level 3 
       Fair Value Measurement at December 31, 2022 Using: 
   Total   Level 1   Level 2   Level 3 
Cash and cash equivalents  $8,258,878   $8,258,878   $   $ 
U.S. government securities   2,397,730        2,397,730     
Corporate debt   1,500,445        1,500,445     
Certificates of deposit   490,603    490,603         
Equity investments   7,721,206    213,016        7,508,190 
Financial instruments, owned, at fair value  $20,368,862   $8,962,497   $3,898,175   $7,508,190 

 

Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows:

   December 31, 2022   Net unrealized losses   Foreign
currency
losses
   Purchases, issuances
and settlements
   September 30,
2023
 
Equity investments  $7,508,190   $(3,327,347)  $(186,395)  $439,454   $4,433,902 

 

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy.

 

10
 

 

Marketable Debt Securities

 

Corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate (“Three-month Libor”). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the Three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets.

 

Equity Investments

 

From 2017 through 2019, the Company made several equity investments in a customer. In the fourth quarter of 2019, the Company reviewed the financial condition and other factors of the customer and, as a result, recorded an impairment charge of $5.2 million to reduce its investment in the customer to zero as of December 28, 2019. In the first quarter of 2022, the customer raised additional equity capital and, based on an observable price change of the customer’s share prices and terms of the equity sale, the Company remeasured the fair market value of its investment and recorded a gain of $4.7 million. In the second quarter of 2022, the Company made an additional equity investment of $0.5 million. During the quarter ended July 1, 2023, the Company received common stock of the equity investment valued at approximately $0.4 million for the payment of royalties. During the three and nine months ended September 30, 2023, the Company also performed an impairment evaluation using an Option Pricing Method and as a result recorded impairment charges of approximately $0 and $3.1 million, respectively. As of September 30, 2023, the Company owned an approximate 2.9% interest in this investment.

 

On September 30, 2019, the Company entered into an Asset Purchase Agreement pursuant to which the Company sold and licensed certain assets of our SolosTM product line and WhisperTM Audio technology. As consideration for the transaction, the Company received a 20.0% equity stake in Solos Incorporation (“Solos Inc.”). The Company’s 20.0% equity stake will be maintained until Solos Inc. has raised a total of $7.5 million in equity financing. Based on the price paid for equity by the other 80.0% owners of Solos Inc. and other factors, the Company estimated the fair value of its equity holdings at $0.6 million and in 2019 recorded a $0.6 million gain on its investment for this equity transaction as the basis of assets transferred was zero. The investment was written down to $0.4 million as a result of an impairment analysis and write down performed in 2020. During the three and nine months ended September 30, 2023, the Company recorded impairment charges of $0 and $0.2 million, respectively.

 

During the three and nine months ended September 30, 2023, the Company recorded approximately $0.1 million and $0.2 million, respectively, of unrealized losses on its equity interest in a company due to a fluctuation in the foreign exchange rate.

 

5. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable consisted of the following:

   September 30, 2023   December 31, 2022 
Accounts receivable  $8,143,214   $6,840,891 
Less — allowance for credit losses   (1,025,000)   (303,000)
Total  $7,118,214   $6,537,891 

 

Changes to the allowance for credit losses for the nine months ended September 30, 2023 were as follows:

 

      
Balance, December 31, 2022  $303,000 
Additions   798,000 
Write-offs   (76,000)
Balance, September 30, 2023  $1,025,000 

 

6. INVENTORY

 

Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 30, 2023 and December 31, 2022:

   September 30, 2023   December 31, 2022 
Raw materials  $5,522,913   $4,285,757 
Work-in-process   2,527,748    1,735,454 
Finished goods   1,023,831    405,189 
Total  $9,074,492   $6,426,400 

 

11
 

 

7. NET LOSS PER SHARE

 

Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of unvested restricted stock.

 

The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period:

  

   Three Months Ended   Three Months Ended <